Literature DB >> 6279348

The natural history of metastatic synovial sarcoma: experience of the Southwest Oncology group.

J R Ryan, L H Baker, R S Benjamin.   

Abstract

Of 35 treated cases of metastatic synovial sarcoma, there was a slight male predominance (60%). The median age was 33 years, with 88% of the patients being white. The lower extremity was the most common primary site, occurring in 66% of the cases. The most common metastatic involvement was pulmonary (33 patients), with only three patients having lymph node involvement. The low incidence of lymph node involvement and the poor prognosis when positive lymph nodes are found suggest that prophylactic lymph node resection is unwarranted. The median time from evidence of metastases to death was ten months. The complete and partial response rate to chemotherapy in this series was 50%; however, duration of the response was rather short with recurrence of metastatic disease a median of seven months after response was first noted. The size of the primary lesion was greater than 5 cm in all but one of the cases. The local recurrence rate was 70% in those cases undergoing local resection and 30% in those cases in which local resection plus irradiation to the primary lesion was undertaken. No case in which radical resection of the primary tumor was undertaken had a local recurrence.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6279348

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  10 in total

1.  Synovial sarcoma: a clinicopathological review.

Authors:  S A Henderson; R Davis; J R Nixon
Journal:  Int Orthop       Date:  1991       Impact factor: 3.075

2.  Synovial sarcoma presenting as an avascular mass: radiologic-pathologic correlation.

Authors:  Ann E McCullough; Adam J Schwartz; Veronica L Taylor; Mark J Kransdorf
Journal:  Skeletal Radiol       Date:  2014-08-01       Impact factor: 2.199

3.  Synovial sarcoma manifesting as a single joint flare in rheumatoid arthritis.

Authors:  A A Borg; C Wynn-Jones; P T Dawes
Journal:  Clin Rheumatol       Date:  1993-03       Impact factor: 2.980

4.  Imaging features of primary and metastatic extremity synovial sarcoma: a single institute experience of 78 patients.

Authors:  A D Baheti; S H Tirumani; R Sewatkar; A B Shinagare; J L Hornick; N H Ramaiya; J P Jagannathan
Journal:  Br J Radiol       Date:  2014-11-28       Impact factor: 3.039

5.  Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.

Authors:  Emily E Carmody Soni; Silke Schlottman; Hayriye V Erkizan; Aykut Uren; Jeffrey A Toretsky
Journal:  Clin Orthop Relat Res       Date:  2014-03       Impact factor: 4.176

6.  Factors influencing survival in metastatic synovial sarcoma: importance of patterns of metastases and the first-line chemotherapy regimen.

Authors:  Samer Salah; Sameer Yaser; Ahmed Salem; Abdellatif Al Mousa; Areej Abu Sheikha; Iyad Sultan
Journal:  Med Oncol       Date:  2013-06-19       Impact factor: 3.064

7.  Metastatic breast tumor arising from synovial sarcoma: report of a case.

Authors:  Yuko Kijima; Heiji Yoshinaka; Michiyo Higashi; Masahiro Yokouchi; Setsuro Komiya; Masanori Hisaoka; Takashi Aikou
Journal:  Surg Today       Date:  2007-03-09       Impact factor: 2.549

8.  Synovial sarcoma mimicking haemophilic pseudotumour.

Authors:  Haroon A Mann; Andrew Hilton; Nicholas J Goddard; Michael A Smith; Brian Holloway; Christine A Lee
Journal:  Sarcoma       Date:  2006

9.  Synovial sarcoma with isolated bone metastases, demonstrated by (99m)Tc-MDP bone scintigraphy and (18)F-FDG PET/CT.

Authors:  Raja Senthil; Raghava Kashyap; Anish Bhattacharya; Bhagwant Rai Mittal
Journal:  Indian J Nucl Med       Date:  2012-01

10.  Surgical management and outcome of synovial sarcoma in the spine.

Authors:  Minglei Yang; Nanzhe Zhong; Chenglong Zhao; Wei Xu; Shaohui He; Jian Zhao; Xinghai Yang; Jianru Xiao
Journal:  World J Surg Oncol       Date:  2018-08-27       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.